Yahoo Web Search

Yahoo

Settings

- All
- Images
- Videos
- News
- Local
- Shopping
More

- Moderna Stock Rises on Earnings Beat and New $3 Billion Stock Buyback
  Barrons.com· 7 days ago
  “We will continue to invest and grow as we have never been as optimistic about Moderna’s future. “...
- Moderna COVID vaccine sales forecast unchanged even as COVAX program cuts orders
  Reuters· 6 days ago
  Moderna Inc (MRNA.O) on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21...
- Moderna maintains vaccine sales view as demand from low-income nations eases
  WSAU Wausau· 7 days ago
  (Reuters) - Moderna Inc on Wednesday retained its full-year sales outlook for COVID-19 shot at $21...
- Moderna's Unaddressed Grey Area (NASDAQ:MRNA)
  Seeking Alpha· 5 days ago
  Moderna (NASDAQ:MRNA) beat both the top and bottom line in Q2, but upon further inspection of their earnings report, there are too many holes to be...
- Moderna 'working really hard' to meet Sept. booster deadline: CEO Bancel
  AOL· 7 days ago
  Moderna (MRNA) reported a strong third quarter Wednesday, boosted by ongoing advance purchase...
- Moderna Reports Second Quarter 2022 Financial Results and Provides Business Updates
  Benzinga· 7 days ago
  Second quarter 2022 revenues of $4.7 billion; GAAP net income of $2.2 billion and GAAP diluted EPS of $5.24Company reiterates advance purchase agreements for expected delivery in 2022 of approximately $21 billionCompany
- Moderna Q2 FY 2022 Earnings Report Recap
  Investopedia· 6 days ago
  Moderna's (MRNA) Q2 earnings and revenue far exceeded analyst expectations as demand stayed strong for its COVID-19 vaccine.